Industry News
Pharmaceutical Industry News
The FDA agreed to re-review…
The FDA agreed to re-review Vanda's previously rejected bid to market its Hetlioz in jet lag disorder, which has been the center of a years-long legal dispute between the two.
In the phase 3 Vesalius-CV study,…
In the phase 3 Vesalius-CV study, Repatha helped significantly curb the risk of major adverse cardiovascular events over standard treatment alone in people who hadn’t had a heart attack or stroke before, Amgen announced.
Vice president Michael Deichmiller…
Vice president Michael Deichmiller says trust, data and a media-first approach are reshaping the industry
Both Acadia Pharmaceuticals and…
Both Acadia Pharmaceuticals and e-therapeutics pulled back the curtain this week on new looks for their respective corporate brand identities.
Director says omnichannel…
Director says omnichannel strategies and patient-first approaches will define the future
BeOne Medicines and AbbVie have…
BeOne Medicines and AbbVie have decided to voluntarily dismiss the patent lawsuit the Big Pharma firm brought against its competitor over their BTK inhibitors.
Ansa Biotechnologies hauled in a…
Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B financing round that will be used to expand the company’s DNA synthesis production capacity in the U.S.
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
In a merger between two…
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi.
Cancer rates are rising in young…
Cancer rates are rising in young adults. Is current care keeping up? Discover how AI and tech can bridge the gap.
In the latest instance of pharma…
In the latest instance of pharma tariff whiplash, the import duties promised by the president last week are reportedly on hold.
On The Top Line, IQVIA’s Marie…
On The Top Line, IQVIA’s Marie Flanagan explains why governance must be built into AI design from the start.
With a government shutdown now in…
With a government shutdown now in effect, the U.S. FDA—already shaken up by head count reductions earlier this year—has sought to keep many of its functions running for the foreseeable future.
AbbVie has kicked off work on a…
AbbVie has kicked off work on a $70 million expansion of its bioresearch center in Worcester, Massachusetts, where the company conducts both manufacturing and R&D for biologic medicines. The project falls under the banner of
A Sanofi spokesperson confirmed to…
A Sanofi spokesperson confirmed to Fierce that it is the company at the center of the investigation.
Bayer’s consumer health unit has…
Bayer’s consumer health unit has named Interpublic Group as its creative, production and media partner, integrating the work at a single agency to boost its buying power and leverage generative AI.
Trump Announces Pfizer Deal to Lower Some Drug Prices and Unveils TrumpRx Website
The administration also announced it will create a website, TrumpRx, that will help consumers buy drugs directly from manufacturers.
Novartis has scored the FDA’s…
Novartis has scored the FDA’s approval for a second BTK inhibitor that’s for a non-cancer indication, teeing off potential competition with Sanofi down the line.
The Sept. 29 settlement was the…
The Sept. 29 settlement was the result of an investigation by New York’s Office of the Attorney General into a county sheriff’s office's purchase of Opvee.
South Korea-based Boryung…
South Korea-based Boryung Corporation is boosting its global oncology foothold with a deal to take on Sanofi’s time-honored chemotherapy Taxotere (docetaxel) in nearly 20 markets.